378 related articles for article (PubMed ID: 16353949)
1. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.
Jayanthi LD; Ramamoorthy S
AAPS J; 2005 Oct; 7(3):E728-38. PubMed ID: 16353949
[TBL] [Abstract][Full Text] [Related]
2. Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters.
Surratt CK; Ukairo OT; Ramanujapuram S
AAPS J; 2005 Oct; 7(3):E739-51. PubMed ID: 16353950
[TBL] [Abstract][Full Text] [Related]
3. Role of monoamine transporters in mediating psychostimulant effects.
Riddle EL; Fleckenstein AE; Hanson GR
AAPS J; 2005 Dec; 7(4):E847-51. PubMed ID: 16594636
[TBL] [Abstract][Full Text] [Related]
4. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
5. A kinome wide screen identifies novel kinases involved in regulation of monoamine transporter function.
Vuorenpää A; Ammendrup-Johnsen I; Jørgensen TN; Gether U
Neurochem Int; 2016 Sep; 98():103-14. PubMed ID: 27020406
[TBL] [Abstract][Full Text] [Related]
6. Monoamine transporters and psychostimulant addiction.
Howell LL; Kimmel HL
Biochem Pharmacol; 2008 Jan; 75(1):196-217. PubMed ID: 17825265
[TBL] [Abstract][Full Text] [Related]
7. Neurotransmitter transporters and their impact on the development of psychopharmacology.
Iversen L
Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S82-8. PubMed ID: 16402124
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.
German CL; Baladi MG; McFadden LM; Hanson GR; Fleckenstein AE
Pharmacol Rev; 2015 Oct; 67(4):1005-24. PubMed ID: 26408528
[TBL] [Abstract][Full Text] [Related]
9. Monoamine transporter as a target molecule for psychostimulants.
Sora I; Li B; Fumushima S; Fukui A; Arime Y; Kasahara Y; Tomita H; Ikeda K
Int Rev Neurobiol; 2009; 85():29-33. PubMed ID: 19607959
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
Han DD; Gu HH
BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
[TBL] [Abstract][Full Text] [Related]
11. Psychostimulants and monoamine transporters: upsetting the balance.
Elliott JM; Beveridge TJ
Curr Opin Pharmacol; 2005 Feb; 5(1):94-100. PubMed ID: 15661632
[TBL] [Abstract][Full Text] [Related]
12. Regulation of monoamine transporters: Role of transporter phosphorylation.
Ramamoorthy S; Shippenberg TS; Jayanthi LD
Pharmacol Ther; 2011 Feb; 129(2):220-38. PubMed ID: 20951731
[TBL] [Abstract][Full Text] [Related]
13. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacology of monoamine neurotransmitter transporters].
Dohi T; Kitayama S; Kumagai K; Hashimoto W; Morita K
Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):315-26. PubMed ID: 12491807
[TBL] [Abstract][Full Text] [Related]
15. Monoamine transporters and psychostimulant drugs.
Rothman RB; Baumann MH
Eur J Pharmacol; 2003 Oct; 479(1-3):23-40. PubMed ID: 14612135
[TBL] [Abstract][Full Text] [Related]
16. [Function of monoamine neurotransmitter transporters].
Sasa M
Nihon Rinsho; 2001 Aug; 59(8):1457-64. PubMed ID: 11519142
[TBL] [Abstract][Full Text] [Related]
17. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.
Hoffman BJ; Hansson SR; Mezey E; Palkovits M
Front Neuroendocrinol; 1998 Jul; 19(3):187-231. PubMed ID: 9665836
[TBL] [Abstract][Full Text] [Related]
18. Expression cloning of a serotonin transporter: a new way to study antidepressant drugs.
Hoffman BJ
Pharmacopsychiatry; 1994 Jan; 27(1):16-22. PubMed ID: 8159777
[TBL] [Abstract][Full Text] [Related]
19. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
Rickli A; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters.
Vaughan RA
J Pharmacol Exp Ther; 2004 Jul; 310(1):1-7. PubMed ID: 15064332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
